Skip to main content
TipRanks
Go Ultimate75% OFF

TaiGen Biopharmaceuticals Holdings Limited (4157) Cash flow

TaiGen Biopharmaceuticals Holdings Limited Cash Flow

TW:4157's free cash flow for Q2 2026 was NT$-41.38M. For the 2026 fiscal year, TW:4157's free cash flow was decreased by NT$-44.00K and operating cash flow was NT$-41.33M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 20.93MNT$ -173.09MNT$ 7.46MNT$ -21.27MNT$ 629.07M
NT$ 83.37MNT$ -110.87MNT$ 145.46MNT$ -84.95MNT$ -306.07M
NT$ -34.64MNT$ -17.40MNT$ -19.99MNT$ -15.84MNT$ -18.85M
NT$ 145.09MNT$ 74.14MNT$ 374.65MNT$ 243.11MNT$ 364.93M
NT$ 16.42MNT$ -175.78MNT$ 65.00KNT$ -28.73MNT$ 617.24M

Currency in TWD

TaiGen Biopharmaceuticals Holdings Limited Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing